Similar articles for PMID: 29173252

Year	Number of Results
2006	1
2010	3
2011	2
2012	4
2013	5
2014	7
2015	14
2016	11
2017	14
2018	21
2019	16
2020	14
2021	6
2022	3
2023	1
2024	0

1

Chronic kidney disease in African Americans: Puzzle pieces are falling into place.

Nally JV Jr. Nally JV Jr. Cleve Clin J Med. 2017 Nov;84(11):855-862. doi: 10.3949/ccjm.84gr.17007. Cleve Clin J Med. 2017. PMID: 29173252 Free article. Review.

2

Cases in Precision Medicine: APOL1 and Genetic Testing in the Evaluation of Chronic Kidney Disease and Potential Transplant.

Neugut YD, Mohan S, Gharavi AG, Kiryluk K. Neugut YD, et al. Ann Intern Med. 2019 Nov 5;171(9):659-664. doi: 10.7326/M19-1389. Epub 2019 Oct 8. Ann Intern Med. 2019. PMID: 31590185 Free PMC article.

3

Apolipoprotein L1 Gene Effects on Kidney Transplantation.

Freedman BI, Locke JE, Reeves-Daniel AM, Julian BA. Freedman BI, et al. Semin Nephrol. 2017 Nov;37(6):530-537. doi: 10.1016/j.semnephrol.2017.07.006. Semin Nephrol. 2017. PMID: 29110760 Free PMC article. Review.

4

APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.

Gutiérrez OM, Irvin MR, Zakai NA, Naik RP, Chaudhary NS, Estrella MM, Limou S, Judd SE, Cushman M, Kopp JB, Winkler CA. Gutiérrez OM, et al. Am J Kidney Dis. 2020 Jan;75(1):54-60. doi: 10.1053/j.ajkd.2019.05.027. Epub 2019 Sep 26. Am J Kidney Dis. 2020. PMID: 31563468 Free PMC article.

5

The Expanding Role of APOL1 Risk in Chronic Kidney Disease and Cardiovascular Disease.

Estrella MM, Parekh RS. Estrella MM, et al. Semin Nephrol. 2017 Nov;37(6):520-529. doi: 10.1016/j.semnephrol.2017.07.005. Semin Nephrol. 2017. PMID: 29110759 Review.

6

Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.

Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project. Young BA, et al. Am J Nephrol. 2019;50(4):303-311. doi: 10.1159/000502675. Epub 2019 Sep 3. Am J Nephrol. 2019. PMID: 31480040 Free PMC article.

7

APOL1 risk variants and kidney disease: what we know so far.

Siemens TA, Riella MC, Moraes TP, Riella CV. Siemens TA, et al. J Bras Nefrol. 2018 Oct-Dec;40(4):388-402. doi: 10.1590/2175-8239-JBN-2017-0033. Epub 2018 Jul 26. J Bras Nefrol. 2018. PMID: 30052698 Free PMC article. Review.

8

African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.

Gordon EJ, Amόrtegui D, Blancas I, Wicklund C, Friedewald J, Sharp RR. Gordon EJ, et al. Am J Kidney Dis. 2018 Dec;72(6):819-833. doi: 10.1053/j.ajkd.2018.07.017. Epub 2018 Oct 22. Am J Kidney Dis. 2018. PMID: 30360961 Free PMC article.

9

An investigation of APOL1 risk genotypes and preterm birth in African American population cohorts.

Robertson CC, Gillies CE, Putler RKB, Ng D, Reidy KJ, Crawford B, Sampson MG. Robertson CC, et al. Nephrol Dial Transplant. 2017 Dec 1;32(12):2051-2058. doi: 10.1093/ndt/gfw317. Nephrol Dial Transplant. 2017. PMID: 27638911 Free PMC article.

10

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

Riella LV, Sheridan AM. Riella LV, et al. Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3. Am J Kidney Dis. 2015. PMID: 26049628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year